scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1468-2982.1985.0502079.X |
P8608 | Fatcat ID | release_r2rylhz6tjh2vovavuslzkmnui |
P698 | PubMed publication ID | 3893732 |
P2093 | author name string | P J Schechter | |
J R Fozard | |||
G P Tell | |||
V Centonze | |||
C Loisy | |||
S Beorchia | |||
P2860 | cites work | Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine | Q36004242 |
Observations on the algogenic actions of adenosine compounds on the human blister base preparation | Q40101529 | ||
Migraine: a biochemical headache? | Q40311465 | ||
The neurobiology of vascular head pain | Q48641194 | ||
Central serotonergic nerves project to the pial vessels of the brain. | Q48716042 | ||
Treatment of the acute migraine attack--current status | Q49117109 | ||
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. | Q53911337 | ||
Special Communication | Q56096168 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | headache | Q86 |
migraine | Q133823 | ||
placebo | Q269829 | ||
P304 | page(s) | 79-82 | |
P577 | publication date | 1985-06-01 | |
P1433 | published in | Cephalalgia | Q5063251 |
P1476 | title | Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study | |
P478 | volume | 5 |
Q37748465 | 5-HT3 receptor antagonists and migraine therapy |
Q37748460 | 5-Hydroxytryptamine and the pathophysiology of migraine |
Q39545540 | Blockade of the flare response to intradermal 5-hydroxytryptamine in man by MDL 72.222, a selective antagonist at neuronal 5-hydroxytryptamine receptors |
Q35888605 | Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites |
Q38010671 | Developments in 5-hydroxytryptamine receptor pharmacology in migraine. |
Q42114573 | Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity |
Q42850031 | Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. |
Q28263827 | On serotonin and migraine: a clinical and pharmacological review |
Q38004465 | Serotonin and nociception |
Q40478013 | Serotonin receptors: Subtypes, functional responses and therapeutic relevance |
Q41331950 | The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications |
Search more.